Correlation Engine 2.0
Clear Search sequence regions

  • abdomen (1)
  • female (1)
  • impairment (1)
  • injuries (1)
  • intact skin (1)
  • patients (1)
  • petroleum (1)
  • skin (9)
  • swine (2)
  • vesicants (1)
  • wound (11)
  • wound skin (2)
  • Sizes of these terms reflect their relevance to your search.

    Reactive Skin Decontamination Lotion (RSDL®) is an FDA-approved skin decontamination kit carried by service members for removal and neutralisation of vesicants and nerve agents. The RSDL kit, comprised of a lotion-impregnated sponge, was shown to be the superior medical decontamination device for chemical warfare agent (CWA) exposure on intact skin. In the event of a chemical exposure situation (i.e. terrorism, battlefield) physical injuries are probable, and preservation of life will outweigh the risk associated with application of RSDL to compromised skin. The purpose of this study was to quantify the rate and quality of wound healing in epidermal skin wounds treated with RSDL in a porcine model. Degree of wound healing was assessed using bioengineering methods to include ballistometry, colorimetry, evaporimetry, and high-frequency ultrasonography. Clinical observation, histopathology and immunohistochemistry were also utilised. All pigs received four bilateral superficial abdominal wounds via a pneumatic dermatome on their ventral abdomen, then were treated with the following dressings over a seven-day period: RSDL sponge, petroleum based Xeroform® gauze, 3 M™ Tegaderm™ Film, and 3 M™ Tegaderm™ Foam. Two additional non-wounded sites on the flank were used as controls. Two groups of pigs were then evaluated for a 21- or 56-day time period, representing short- and long-term wound-healing progression. Our findings indicated RSDL had a negative impact on wound-healing progression at both 21 and 56 days post-injury. Wounds receiving RSDL demonstrated a decreased skin elasticity, significant transepidermal water loss, and altered skin colouration and thickness. In addition, the rate of wound healing was delayed, and return to a functional skin barrier was altered when compared to non-RSDL-treated wounds. In conclusion, wound management care and clinical therapeutic intervention plans should be established to account for a prolonged duration of healing in patients with RSDL-contaminated wounds.


    Jessica M Connolly, Robert S Stevenson, Roy F Railer, Offie E Clark, Kimberly A Whitten, Robyn B Lee-Stubbs, Dana R Anderson. Impairment of wound healing by reactive skin decontamination lotion (RSDL®) in a Göttingen minipig® model. Cutaneous and ocular toxicology. 2020 Jun;39(2):143-157

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32321319

    View Full Text